The latest report to chronicle the rising cost of prescription medicines comes from a U.S. Senate committee that found prices for the 20 drugs most widely prescribed through Medicare Part D in 2015, on average, increased 12 percent each year between 2012 and 2017.

Moreover, a dozen of the medicines saw price hikes of 50 percent of more during that time and six of the drugs experienced price increases of more than 100 percent. In one case, the weighted average wholesale cost for one medicine — Nitrostat, which is used to prevent chest pain — rose by 477 percent.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • The takeaway would seem to be that analysis is really speculation when the real numbers are secret? Who designed the rules of this game?

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy